Skip to content
★ Sign in to follow
JE

James E. Rouse

Arrhythmia Research Technology Inc /DE/
Total declarations
10
Company
1
▲ Purchases (3 ops.)
€14k
▼ Sales (5 ops.)
€135k

Latest filing published 19 Sept 2011 for ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, €4,972.

Insider track record

Disclosed buys
3
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-10.9%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

James E. Rouse: trading record in brief

James E. Rouse discloses dealings in Arrhythmia Research Technology Inc /DE/ to SEC (Form 4). We count 10 filings; the first trade dates from 8 December 2006 and the latest from 15 September 2011.

In open-market terms, that means 3 purchases worth €14k on one side and 5 sales worth €135k on the other. Netting one side against the other leaves €121k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2011 alone, the filings show 3 purchases and no sales.

In size, the median ticket on the buying side is €4,972. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -10.9%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 19 September 2011, reports an open-market purchase of €4,972 in Arrhythmia Research Technology Inc /DE/. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to James E. Rouse

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations